Reuters -- Canadian drugmaker Labopharm Inc said on Tuesday that U.S. regulators have accepted its latest filing regarding the antidepressant trazodone and that a decision on the drug could come in February.
Reuters -- Canadian drugmaker Labopharm Inc said on Tuesday that U.S. regulators have accepted its latest filing regarding the antidepressant trazodone and that a decision on the drug could come in February.
